FTC v. Abbvie
FTC v. Abbvie involved litigation about a patent for a “blockbuster testosterone replacement therapy.” The 3rd Circuit held that the District Court erred by rejecting the FTC’s reverse-payment theory and in concluding
FTC v. Abbvie involved litigation about a patent for a “blockbuster testosterone replacement therapy.” The 3rd Circuit held that the District Court erred by rejecting the FTC’s reverse-payment theory and in concluding
Copyright Sullivan Legal Writing Services
All rights reserved.